Keeping the lock on smallpox

Nature Medicine

Volumn 9, Issue 9, 2003, Pages 1115-1116

  Weiner, David B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; SMALLPOX VACCINE;

CELLULAR IMMUNITY; ERADICATION THERAPY; IMMUNITY; PRIORITY JOURNAL; SHORT SURVEY; SMALLPOX; T LYMPHOCYTE SUBPOPULATION; TISSUE CULTURE; VACCINATION; VACCINE PRODUCTION; VIRUS INFECTION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CLINICAL TRIALS; HUMANS; SMALLPOX; SMALLPOX VACCINE; T-LYMPHOCYTES; TIME FACTORS; VACCINATION;

ANIMALIA; VARIOLA VIRUS;

EID: 0141625679     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0903-1115     Document Type: Short Survey

References (16)

1. Alibek, K. Biohazard (ed. Handelman, S.) 107-122 (Delta Publishing, New York, 1999).
2. Preston, R. The Demon in the Freezer 1-49 (Random House, New York, 2002).
3. Gellman, B. 4 nations thought to possess smallpox. Iraq, N. Korea named, two officials say. Washington Post November 5 (2002), p.A1.
4. Henderson, D.A. The looming threat of bioterrorism. Science 283, 1279-1282 (1999).
5. LeDuc, J.W. & Becher, R. Current status of smallpox vaccine. Emerg. Infect. Dis. 5, 593-594 (1999).
6. Hammarlund, E. et al. Duration of antiviral immunity after smallpox vaccination. Nat. Med. 9, 1131-1137 (2003).
7. Weltzin, R. et al. Clonal vaccinia virus grown in cell culture as a new smallpox vaccine. Nat. Med. 9, 1125-1130 (2003).
8. Kaplan, E.H, Craft, D.L. & Wein, L.M. Emergency response to smallpox attack: the case for mass vaccination. Proc. Natl. Acad. Sci. USA 99, 10935-10940 (2002).
9. Rosenthal, S.R., Merchlinsky, M., Kleppinger, C. & Goldenthal, K.L. Developing new smallpox vaccines. Emerg. Infect. Dis. 7, 1-12 (2001).
10. Mack, T.M., Nobel, J.R. & Thomas, D.B. A prospective study of serum antibody and protection against smallpox. Am. J. Trop. Hyg. 21, 214-218 (1972).
11. Frwy, S.E., Newman, F.K., Yan, L. & Belshe, R.B. Responses to smallpox vaccine in persons immunized in the distant past. JAMA 289, 3295-3299 (2003).
12. McConkey, S.J. et al. Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat. Med. 9, 729-735 (2003).
13. Copeman, P.W.M. & Wallace, H.J. Eczema vaccinatum. Br. Med. J. 2, 906-908 (1964).
14. Cangemi, V.F. Acute pericarditis after smallpox vaccination. N. Engl. J. Med. 258, 1257 (1958).
15. Neff, J.M. et al. Complications of smallpox vaccination. I. National survey in the United States, 1963. N. Engl. J. Med. 276, 125-132 (1967).
16. Lane, J.M., Ruben, F.L., Abrutyn, E. & Millar, J.D. Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968. JAMA 212, 441-444 (1970).